Assist. Prof. Dr. Adonis Sfera | Molecular Science | Best Faculty Award
Assist. Prof. Dr. Adonis Sfera, Patton State Hospital, United States
Dr. Adonis Sfera is a highly experienced psychiatrist and clinical researcher, currently serving as the Chief of Professional Education at Patton State Hospital, USA. With a career spanning over four decades, he has contributed extensively to schizophrenia research and clinical psychiatry, alongside roles in family therapy and psychopharmacological studies. He has led numerous research trials on psychotropic medications and Alzheimer’s disease treatments. Dr. Sfera is dedicated to advancing mental health education and research, and his work has had a significant impact on psychiatric care and medical missions in Mexico. His professional affiliations include the American Society of Addiction Medicine, the American Academy of Psychosomatic Medicine, and the Collegium Internationale Neuro-Psychopharmacologicum (CINP).
PROFILE
Educational Details
M.D. in General Medicine – Institution of Medicine and Pharmacy, Timisoara, Romania (1980).
Residency in Psychiatry – Los Angeles County/University of Southern California Medical Center, Los Angeles, CA (1992-1996).
Professional Experience
Dr. Adonis Sfera is a distinguished psychiatrist and healthcare professional with extensive clinical and academic experience. Since 2016, he has served as the Chief of Professional Education at Patton State Hospital. Previously, he held the position of Staff Psychiatrist at Patton State Hospital from 2013 to 2016, affiliated with the University of California, Riverside (UCR). Dr. Sfera’s career in psychiatry spans over several decades, with a focus on schizophrenia research and clinical trials from 1996 to 2013. He has also worked as a research faculty member at the University of Southern California (1996-2006) and served as a child and adolescent psychiatrist for Orange County Mental Health (1996-1998).
Earlier in his career, Dr. Sfera completed residency training in general psychiatry at the Los Angeles County/USC Medical Center, with rotations that included child/adolescent psychiatry, geriatric and forensic psychiatry, emergency psychiatry, and AIDS-related psychiatric care. He has also had extensive experience working in physical therapy and family therapy prior to his specialization in psychiatry.
Dr. Sfera’s research focuses primarily on schizophrenia, psychopharmacology, and clinical trials related to psychiatric treatments. He has served as the Principal Investigator for multiple significant clinical trials, including studies on agomelatine for Major Depressive Disorder (MDD), Donepezil (Aricept) for Alzheimer’s Disease, and various treatments for schizophrenia. His early work in psychopharmacology involved research on depressive disorders in children and adolescents at the University of Belgrade.
Dr. Sfera is also deeply committed to medical education, with a particular focus on research ethics, clinical rating scales, and psychopharmacology. He has been involved in training and leading courses in research principles, Institutional Review Board (IRB) practices, and psychopharmacology at institutions like the University of Southern California and through the Master Psychopharmacology NEI Program.
Professional Memberships
American Society of Addiction Medicine
American Academy of Psychosomatic Medicine
CINP (Collegium Internationale Neuro-Psychopharmacologicum)
Voluntary Projects
National Association for Mental Illness (NAMI) – 2000–Current
Medical missions to Mexico – 1997–2007
Neurolipidomics in schizophrenia: A not so well-oiled machine
Authors: del Campo, C.M.Z.-M., Nicolson, G.L., Sfera, A.
Journal: Neuropharmacology (2024)
Volume/Issue: 260, 110117
Citations: 0
Novel Insights into Psychosis and Antipsychotic Interventions: From Managing Symptoms to Improving Outcomes
Authors: Sfera, A., Imran, H., Sfera, D.O., Kozlakidis, Z., Hazan, S.
Journal: International Journal of Molecular Sciences (2024)
Volume/Issue: 25(11), 5904
Citations: 0
Insomnia in Forensic Detainees: Is Salience Network the Common Pathway for Sleep, Neuropsychiatric, and Neurodegenerative Disorders?
Authors: Sfera, A., Thomas, K.A., Ogunjale, I.A., Jafri, N., Bota, P.G.
Journal: Journal of Clinical Medicine (2024)
Volume/Issue: 13(6), 1691
Citations: 0
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
Authors: Sfera, A., Andronescu, L., Britt, W.G., Rahman, L., Kozlakidis, Z.
Journal: International Journal of Molecular Sciences (2023)
Volume/Issue: 24(21), 15797
Citations: 0
Long COVID as a Tauopathy: Of “Brain Fog” and “Fusogen Storms”
Authors: Sfera, A., Rahman, L., Zapata-Martín del Campo, C.M., Kozlakidis, Z.
Journal: International Journal of Molecular Sciences (2023)
Volume/Issue: 24(16), 12648
Citations: 4
Recent Developments in Protein Lactylation in PTSD and CVD: Novel Strategies and Targets
Authors: Kozlakidis, Z., Shi, P., Abarbanel, G., Klein, C., Sfera, A.
Journal: BioTech (2023)
Volume/Issue: 12(2), 38
Citations: 1
Microbial Translocation Disorders: Assigning an Etiology to Idiopathic Illnesses
Authors: Sfera, A., Hazan, S., Klein, C., Kozlakidis, Z., Nicolson, G.L.
Journal: Applied Microbiology (2023)
Volume/Issue: 3(1), pp. 212–240
Citations: 1
Microbiota-derived psychedelics: Lessons from COVID-19
Authors: Sfera, A., Hazan, S., Kozlakidis, Z., Klein, C.
Journal: Advances in Clinical and Experimental Medicine (2023)
Volume/Issue: 32(4), pp. 395–399
Citations: 5
Long COVID and the Neuroendocrinology of Microbial Translocation Outside the GI Tract: Some Treatment Strategies
Authors: Sfera, A., Osorio, C., Hazan, S., Andronescu, C.V., Nicolson, G.L.
Journal: Endocrines (2022)
Volume/Issue: 3(4), pp. 0
Citations: 4
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
Authors: Sfera, A., Hazan, S., Anton, J.J., Rahman, L., Kozlakidis, Z.
Journal: Frontiers in Pharmacology (2022)
Volume/Issue: 13, 995481
Citations: Not provided in your details
Conclusion
Dr. Adonis Sfera’s qualifications and experience align closely with the criteria for the Research for Best Faculty Award. His longstanding career in psychiatric research, leadership in clinical trials, contributions to academic education, active professional memberships, and commitment to mental health advocacy all position him as an outstanding candidate for this prestigious award.